Nereid Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nereid Therapeutics's estimated annual revenue is currently $1.4M per year.
- Nereid Therapeutics's estimated revenue per employee is $77,500
- Nereid Therapeutics's total funding is $50M.
Employee Data
- Nereid Therapeutics has 18 Employees.
- Nereid Therapeutics grew their employee count by 20% last year.
Nereid Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Discovery Biology and High Throughput Screening | Reveal Email/Phone |
2 | Principal Scientist | Reveal Email/Phone |
3 | Principal Scientist | Reveal Email/Phone |
Nereid Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nereid Therapeutics?
Nereid Therapeutics, an ATP company, is discovering new disease treatments using proprietary state-of-the-art technologies for generating, visualizing, and measuring liquid-liquid phase separation and resulting biomolecular condensates. Nereid applies leading expertise in soft matter physics and cell biology to pioneer completely new ways to fight intractable diseases. For more information, visit www.nereidtx.com.
keywords:N/A
$50M
Total Funding
18
Number of Employees
$1.4M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nereid Therapeutics News
BOSTON, Nov. 1, 2021 /PRNewswire/ -- Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announced today the members of its Scientific Advisory Board (SAB): Cigall Kadoch, Ph.D., Alexander McCampbell, Ph. ...
BOSTON, Oct. 25, 2021 /PRNewswire/ -- Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announces the appointment of Laura L. Forese, M.D., MPH, and Rupert Vessey, FRCP, Ph.D., to its Board of Directors ...
Nereid Therapeutics, a Boston, MA-based company dedicated to discovering new disease treatments by applying research and technologies in biomolecular condensates, raised $50m in Series A funding. Apple Tree Partners (ATP), a life sciences venture firm, created Nereid with Clifford P. Brangwynne ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 18 | -22% | $13M |
#2 | $1.5M | 18 | -36% | N/A |
#3 | $0.5M | 18 | -5% | $9.5M |
#4 | $2.2M | 18 | -5% | N/A |
#5 | $0.6M | 18 | 0% | $4.7M |